Life Healthcare Group Stock EBITDA
| LTGHY Stock | USD 3.58 0.04 1.13% |
Life Healthcare Group fundamentals help investors to digest information that contributes to Life Healthcare's financial success or failures. It also enables traders to predict the movement of Life Pink Sheet. The fundamental analysis module provides a way to measure Life Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Life Healthcare pink sheet.
Life |
Life Healthcare Group Company EBITDA Analysis
Life Healthcare's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Life Healthcare EBITDA | 3.24 B |
Most of Life Healthcare's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Life Healthcare Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Life Healthcare Group reported earnings before interest,tax, depreciation and amortization of 3.24 B. This is 268.92% higher than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The ebitda for all United States stocks is 16.97% higher than that of the company.
Life EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Life Healthcare's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Life Healthcare could also be used in its relative valuation, which is a method of valuing Life Healthcare by comparing valuation metrics of similar companies.Life Healthcare is currently under evaluation in ebitda category among its peers.
Life Fundamentals
| Return On Equity | 0.0878 | |||
| Return On Asset | 0.0404 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 2.06 B | |||
| Shares Outstanding | 360.93 M | |||
| Price To Earning | 18.63 X | |||
| Price To Book | 1.27 X | |||
| Price To Sales | 0.05 X | |||
| Revenue | 28.21 B | |||
| Gross Profit | 8.36 B | |||
| EBITDA | 3.24 B | |||
| Net Income | 1.53 B | |||
| Cash And Equivalents | 1.15 B | |||
| Cash Per Share | 3.16 X | |||
| Total Debt | 10.33 B | |||
| Debt To Equity | 0.65 % | |||
| Current Ratio | 0.61 X | |||
| Book Value Per Share | 51.94 X | |||
| Cash Flow From Operations | 4.23 B | |||
| Earnings Per Share | 0.23 X | |||
| Number Of Employees | 45 | |||
| Beta | 0.31 | |||
| Market Capitalization | 1.36 B | |||
| Total Asset | 42.24 B | |||
| Working Capital | (1.49 B) | |||
| Current Asset | 3.1 B | |||
| Current Liabilities | 4.59 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 42.24 B | |||
| Last Dividend Paid | 0.4 |
About Life Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Life Healthcare Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Life Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Life Healthcare Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Life Pink Sheet Analysis
When running Life Healthcare's price analysis, check to measure Life Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Healthcare is operating at the current time. Most of Life Healthcare's value examination focuses on studying past and present price action to predict the probability of Life Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Healthcare's price. Additionally, you may evaluate how the addition of Life Healthcare to your portfolios can decrease your overall portfolio volatility.